期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 354, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jneuroim.2021.577520
关键词
Regulatory B cells; B10 cells; Interleukin-10; Multiple sclerosis; Therapeutic strategy
资金
- National Natural Science Foundation of China [81801195, 81771295]
- Innovative Research Team of Highlevel Local Universities in Shanghai and Shanghai Sailing Program [18YF1413100]
This review focuses on the unique roles of immunoregulatory B10 cells in multiple sclerosis (MS), including their identification and development, signals that promote IL-10 production, and the potential and challenges of B10-based therapies for MS.
Regulatory B cells are a rare B-cell subset widely known to exert their immunosuppressive function via the production of interleukin-10 (IL-10) and other mechanisms. B10 cells are a special subset of regulatory B cells with immunoregulatory function that is fully attributed to IL-10. Their unique roles in the animal model of multiple sclerosis (MS) have been described, as well as their relevance in MS patients. This review specifically focuses on the identification and development of B10 cells, the signals that promote IL-10 production in B cells, the roles of B10 cells in MS, and the potential and major challenges of the application of B10-based therapies for MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据